Početna › Nedostatak alfa-1 antitripsina › Texas
Kliničke studije za Nedostatak alfa-1 antitripsina u državi Texas
4 studija za Nedostatak alfa-1 antitripsina traži sudionike na lokacijama u državi Texas.
Službeni tekst studije (engleski)
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 11. kol 2026. · NCT07555483Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Texoma Liver Center, Denison
- Baylor College of Medicine Medical Center, Houston
- The Texas Liver Institute, San Antonio
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 13. svi 2026. · NCT05677971Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- Texas Liver Institute American Research Corporation, San Antonio
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 5. ožu 2026. · NCT06165341A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
- Renovatio Clinical, The Woodlands
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 22. srp 2025. · NCT06049082Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.